<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Penn State: Judging Session</title>
        <link>https://video.igem.org/videos/watch/6238ba54-a31e-4634-85a1-078db529c936</link>
        <description>Advanced stage carcinomas are difficult to target for a myriad of reasons, ranging from complications in tumor identification to targetability. TROP-2, a transmembrane glycoprotein, is overexpressed in epithelial cancers with poor prognoses. Furthermore, miRNA34𝛼, a small, non-coding RNA molecule downstream of the tumor suppressor p53 pathway, shows promise as a cancer therapeutic. Our project engineered a novel delivery platform, a miR-34𝛼 payload in S. cerevisiae exosomes coated with anti-TROP-2 nanobodies, to assess the effectiveness of exosome delivery mechanisms in an in-vitro pancreatic cancer model.</description>
        <lastBuildDate>Sat, 21 Nov 2026 11:35:03 GMT</lastBuildDate>
        <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
        <generator>PeerTube - https://video.igem.org</generator>
        <image>
            <title>Penn State: Judging Session</title>
            <url>https://video.igem.org/client/assets/images/icons/icon-1500x1500.png</url>
            <link>https://video.igem.org/videos/watch/6238ba54-a31e-4634-85a1-078db529c936</link>
        </image>
        <copyright>All rights reserved, unless otherwise specified in the terms specified at https://video.igem.org/about and potential licenses granted by each content's rightholder.</copyright>
        <atom:link href="https://video.igem.org/feeds/video-comments.xml?videoId=6238ba54-a31e-4634-85a1-078db529c936" rel="self" type="application/rss+xml"/>
    </channel>
</rss>